Home The Book Dr Articles Products Message Boards Journal Articles Search Our Surveys Surgery ESWT Dr Messages Find Good Drs video

Hello John Warlick

Posted by BillC on 7/14/99 at 00:00 (008696)

John,

What is the status on the Ossatron study for treating PF? When will it be approved? How many people have been treated with PF. What are the locations in the US that will have the Ossatron. Can we get Email updates on the status periodically?


Re: Hello John Warlick

Ossatron on 7/14/99 at 00:00 (008713)

Bill,

250 patients have been enrolled in the double blind study. The last patient should be treated the first or second week of august. After the last patient has been treated, we must wait a minimum of 12 weeks to break the blind and evaluate the study. Currently, study sites are in Chattanooga, Atlanta, Ft. Lauderdale, Houston, Rochester, St. Louis and soon - LA. Worldwide, over 7,500 patients have been treated on the ossatron for pf. At least twice that many treatments have occured on the other competitive devices due to their high retreatment rates. As per email updates, let me work on that. We will post that data on our website healthtronics.com after we complete our IPO later this month. We are in a quiet period and accordingly have been ignoring our website. Thanks for your interest. Wish us luck.


Re: Hello John Warlick

Ossatron on 7/14/99 at 00:00 (008713)

Bill,

250 patients have been enrolled in the double blind study. The last patient should be treated the first or second week of august. After the last patient has been treated, we must wait a minimum of 12 weeks to break the blind and evaluate the study. Currently, study sites are in Chattanooga, Atlanta, Ft. Lauderdale, Houston, Rochester, St. Louis and soon - LA. Worldwide, over 7,500 patients have been treated on the ossatron for pf. At least twice that many treatments have occured on the other competitive devices due to their high retreatment rates. As per email updates, let me work on that. We will post that data on our website healthtronics.com after we complete our IPO later this month. We are in a quiet period and accordingly have been ignoring our website. Thanks for your interest. Wish us luck.